Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 6
1999 11
2000 8
2001 6
2002 6
2003 9
2004 15
2005 8
2006 15
2007 11
2008 14
2009 11
2010 19
2011 30
2012 29
2013 32
2014 34
2015 35
2016 40
2017 32
2018 33
2019 34
2020 42
2021 76
2022 54
2023 66
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

602 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists.
Mauricio D, Escalada J, Pérez A, Romero-Gómez M, Cusi K, Younoussi ZM, Lazarus JV. Mauricio D, et al. Among authors: romero gomez m. Endocrinol Diabetes Nutr (Engl Ed). 2024 Apr;71(4):149-151. doi: 10.1016/j.endien.2024.01.007. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 38735676 No abstract available.
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R, Fernández-Rodríguez C, Maya-Miles D, Diago M, Poca M, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Hernández-Guerra M, Pareja-Megia MJ, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Turnes J, Romero-Gómez M; HEPAmet Registry. Ampuero J, et al. Among authors: romero gomez m. J Gastroenterol. 2024 Apr 15. doi: 10.1007/s00535-024-02098-8. Online ahead of print. J Gastroenterol. 2024. PMID: 38619600
LiverAI: New tool in the landscape for liver health.
Marti-Aguado D, Pazó J, Diaz-Gonzalez A, de Las Heras Páez de la Cadena B, Conthe A, Gallego Duran R, Rodríguez-Gandía MA, Turnes J, Romero-Gomez M. Marti-Aguado D, et al. Among authors: romero gomez m. Gastroenterol Hepatol. 2024 Apr 4:S0210-5705(24)00075-X. doi: 10.1016/j.gastrohep.2024.04.001. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38582150 English, Spanish. No abstract available.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. Among authors: romero gomez m. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
McTeer M, Applegate D, Mesenbrink P, Ratziu V, Schattenberg JM, Bugianesi E, Geier A, Romero Gomez M, Dufour JF, Ekstedt M, Francque S, Yki-Jarvinen H, Allison M, Valenti L, Miele L, Pavlides M, Cobbold J, Papatheodoridis G, Holleboom AG, Tiniakos D, Brass C, Anstee QM, Missier P; LITMUS Consortium investigators. McTeer M, et al. Among authors: romero gomez m. PLoS One. 2024 Feb 29;19(2):e0299487. doi: 10.1371/journal.pone.0299487. eCollection 2024. PLoS One. 2024. PMID: 38421999 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
602 results